Traumatic Cardiac Arrest
Traumatic Cardiac Arrest Registry
This retrospective data repository will serve as a means to aggregate and analyze order of pre-hospital care (intubation, medication, etc) as it relates to Traumatic cardiac arrest.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
The primary objective of this study is to establish a data repository that will be permissive of quality improvement studies/observations specific to patients with Traumatic cardiac arrest and evaluate impact of sequence of pre-hospital care in survival outcomes.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75203
- Methodist Dallas Medical Center- Clinical Research Institute
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
patients with traumatic cardiac arrest(TCA) have poor chances at survival despite rapid trauma activation responses. The traditional rescue sequence, focusing on airway, breathing, and circulation(ABC), has become standard of care for initial resuscitation for both trauma and non-trauma patients.
Description
Inclusion Criteria:
≥18 years old Included in the MDMC Trauma Registry Cardiac arrest in pre-hospital setting or trauma bay
Exclusion Criteria:
<18 years old Prisoners, pregnant persons, or other protected population
Study Plan
How is the study designed?
Design Details
- Observational Models: OTHER
- Time Perspectives: OTHER
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Total Number and Description of Study Sites/Total Number of Subjects Projected
This study will include all trauma patients who meet registry inclusion and arrive at the Methodist Dallas Medical Center(MDMC) trauma bay with Traumatic cardiac arrest. Enrollment will terminate once 5 years of data are captured: January 2018 through December 2023. |
The MDMC Trauma Registry will be queried for demographic information, diagnosis codes, admission dates, traumatic injury characteristics, surgical procedures, comorbidities, inpatient outcomes, complications, consultations, discharge location, and mortality. Additional laboratory values will be abstracted from Epic through retrospective chart review. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total Number of Study Sites
Time Frame: 5 years
|
This study will include all trauma patients who meet registry inclusion and arrive at the Methodist Dallas Medical Center (MDMC) trauma bay with Traumatic cardiac arrest. |
5 years
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Andrew Karpisek, MD, Methodist Health System
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 052.TRA.2023.D
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
All information will be blinded in compliance with Good Clinical Practice.The investigator will make all possible efforts to ensure compliance with all policies regarding sharing of Protected Health Information or research information. Only de-identified Protected Health Information will be shared in relevant research mediums.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.